HAG
NVAX icon

HighPoint Advisor Group’s Novavax NVAX Stock Holding History

HighPoint Advisor Group’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$234K Buy
+1,129
New +$249K 0.02% 467
2021
Q2 		– Sell
-4,330
Closed -$778K – 563
2021
Q1 		$778K Sell
4,330
-4,877
-53% -$972K 0.09% 182
2020
Q4 		$2.91M Buy
+9,207
New +$979K 0.35% 64

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HighPoint Advisor Group's NVAX Position: Q3 2021 in Review

HighPoint Advisor Group opened a new position in Novavax (NVAX) in Q3 2021: 1,129 shares worth $234K. The stake represents 0.02% of the portfolio and ranks #467 among its holdings. This is a return to the name: HighPoint Advisor Group previously reported a position in NVAX as recently as Q1 2021.

HighPoint Advisor Group first reported a position in NVAX in Q4 2020 and has held it in 3 quarters since. The position peaked at $2.91M in Q4 2020. 443 funds tracked by Wall St. Rank hold NVAX as of Q3 2021.

  • HighPoint Advisor Group held 1,129 shares of Novavax worth $234K as of Q3 2021.
  • Novavax was a new HighPoint Advisor Group position in Q3 2021.
  • Novavax made up 0.02% of HighPoint Advisor Group's portfolio in Q3 2021, its #467 holding.
  • HighPoint Advisor Group first reported a position in Novavax in Q4 2020 and has held it in 3 quarters since.
  • HighPoint Advisor Group's Novavax position peaked at $2.91M in Q4 2020.
  • 443 funds tracked by Wall St. Rank held Novavax as of Q3 2021.

Based on HighPoint Advisor Group's 13F filing for Q3 2021, filed 15 Nov 2021.